Company
CStone Pharmaceuticals
拓新药时代 筑健康基石
- Status
- IPOas of 2026-09-18Source (opens in a new tab)
- Headquarters
- Suzhou, China
- Founded
- 2015
- Legal name
- CSTONE PHARMACEUTICALS
Claim, correct or request removal
Record updated 18 September 2026
About
基石药业 (CStone Pharmaceuticals; HKEX code: 2616) was founded at the end of 2015 and is an innovation-driven biopharmaceutical company focused on the R&D of drugs in key disease areas such as oncology and immunology and inflammation, committed to meeting the urgent medical needs of patients in China and worldwide.
About the company
- Status notes
- 香港联交所代码: 2616
Products
- Other
- CS2009
- Other
- CS5007
- Other
- 普拉替尼胶囊
- Other
- 舒格利单抗
Loading relationship preview